Your browser doesn't support javascript.
loading
How do successive vaccinations and SARS-CoV-2 infections impact humoral immunity dynamics: An 18-month longitudinal study.
Diep, A N; Schyns, J; Gourzones, C; Goffin, E; Papadopoulos, I; Moges, S; Minner, F; Ek, O; Bonhomme, G; Paridans, M; Gillain, N; Husson, E; Garigliany, M; Darcis, G; Saegerman, C; Desmecht, D; Guillaume, M; A F, Donneau; Bureau, F; Gillet, L.
Afiliação
  • Diep AN; Biostatistics and Research Method Center - Public Health Department, Liège University, 4000 Liège, Belgium.
  • Schyns J; Laboratory of Cellular and Molecular Immunology, GIGA Institute, Liège University, 4000 Liège, Belgium; COVID-19 Platform, Liège University, 4000 Liège, Belgium.
  • Gourzones C; COVID-19 Platform, Liège University, 4000 Liège, Belgium; Laboratory of Immunology-Vaccinology, FARAH, Liège University, 4000 Liège, Belgium.
  • Goffin E; COVID-19 Platform, Liège University, 4000 Liège, Belgium; Laboratory of Immunology-Vaccinology, FARAH, Liège University, 4000 Liège, Belgium.
  • Papadopoulos I; Biostatistics and Research Method Center - Public Health Department, Liège University, 4000 Liège, Belgium.
  • Moges S; Biostatistics and Research Method Center - Public Health Department, Liège University, 4000 Liège, Belgium.
  • Minner F; COVID-19 Platform, Liège University, 4000 Liège, Belgium.
  • Ek O; COVID-19 Platform, Liège University, 4000 Liège, Belgium.
  • Bonhomme G; Department of Pathology, FARAH, Liège University, 4000 Liège, Belgium.
  • Paridans M; From Biostatistics to Health Promotion Research Unit, Public Health Department, Liège University, 4000 Liège, Belgium.
  • Gillain N; Biostatistics and Research Method Center - Public Health Department, Liège University, 4000 Liège, Belgium; From Biostatistics to Health Promotion Research Unit, Public Health Department, Liège University, 4000 Liège, Belgium.
  • Husson E; Biostatistics and Research Method Center - Public Health Department, Liège University, 4000 Liège, Belgium; From Biostatistics to Health Promotion Research Unit, Public Health Department, Liège University, 4000 Liège, Belgium.
  • Garigliany M; Department of Pathology, FARAH, Liège University, 4000 Liège, Belgium.
  • Darcis G; Infectious Diseases Department, University Hospital of Liège, 4000 Liège, Belgium.
  • Saegerman C; Research Unit in Epidemiology and Risk Analysis applied to Veterinary Sciences, FARAH, Liège University, 4000 Liège, Belgium.
  • Desmecht D; Department of Pathology, FARAH, Liège University, 4000 Liège, Belgium.
  • Guillaume M; From Biostatistics to Health Promotion Research Unit, Public Health Department, Liège University, 4000 Liège, Belgium.
  • A F D; Biostatistics and Research Method Center - Public Health Department, Liège University, 4000 Liège, Belgium.
  • Bureau F; Laboratory of Cellular and Molecular Immunology, GIGA Institute, Liège University, 4000 Liège, Belgium; COVID-19 Platform, Liège University, 4000 Liège, Belgium.
  • Gillet L; COVID-19 Platform, Liège University, 4000 Liège, Belgium; Laboratory of Immunology-Vaccinology, FARAH, Liège University, 4000 Liège, Belgium. Electronic address: L.gillet@uliege.be.
J Infect ; 88(2): 183-186, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37981216
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Bélgica